Seres Therapeutics Inc (MCRB NASDAQ) stock market data APIs
$13.509
1.39(10.3%)
as of February 4, 2026
Try our APIs with
free plan!
Seres Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize gastrointestinal pathogens, enhance epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. Its other pipeline programs include SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease; and SER-287 and SER-301, which are in clinical trials for the treatment of mild-to-moderate ulcerative colitis. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Prev. Close
13.509
Open
14.9003
High
15.2638
Low
12.9894
52 wk Range
6.53-29.98
Market Cap
123 M
P/E Ratio
17.4744
Shares Outstanding
9 047 K
Revenue
351 K
EPS
0.94
Beta
0.25
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Seres Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Seres Therapeutics Inc data using free add-ons & libraries
Get Seres Therapeutics Inc Fundamental Data
Seres Therapeutics Inc Fundamental data includes:
- Net Revenue: 351 K
- EBITDA: -99 165 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.0397
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Seres Therapeutics Inc News
New
Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy
Data demonstrate clinical translation of VOWST mechanisms of action in both first and multiply recurrent CDI patients Seres MbTx® platform provides high-resolution functional biological understandin...
3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround
2025 was a catalyst year for biotech and drug stocks. While the year began on a cautious note for the sector due to concerns over potential tariffs on pharmaceutical imports, the sector rebounded in t...
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
Seres Therapeutics, Inc. CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will part...
Seres Therapeutics GAAP EPS of $0.94 beats by $0.52, revenue of $0.35M
* Seres Therapeutics press release [https://seekingalpha.com/pr/20293885-seres-therapeutics-reports-third-quarter-2025-financial-results-and-provides-business-updates] (MCRB [https://seekingalpha.co...
Get Seres Therapeutics Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
